Eppendorf India and Rajalakshmi Engineering College extend MoU to enhance biotechnology training for students: Our Bureau, ...
DCC recommends making Sugam portal database of all products with brand names accessible to public: Gireesh Babu, New Delhi ...
Tharimmune acquires global license and partners with Intract Pharma to develop an oral formulation of infliximab: Bridgewater, New Jersey Tuesday, September 17, 2024, 14:00 Hrs [I ...
Poseida Therapeutics’ P-BCMA-ALLO1 receives US FDA RMAT designation to treat relapsed/refractory multiple myeloma: San Diego Tuesday, September 17, 2024, 17:00 Hrs [IST] Poseida ...
Accuray bridging gap of India's escalating cancer burden with latest version of Radixact radiation therapy: Our Bureau, Bengaluru Tuesday, September 17, 2024, 14:15 Hrs [IST] Accu ...
Orchid Pharma sets up Orchid AMS division, to combat the rising threat of antimicrobial resistance: Our Bureau, Bengaluru Tuesday, September 17, 2024, 16:15 Hrs [IST] Orchid Pharm ...
FIP supports education on substandard and falsified medicines sold online with new handbook: Our Bureau, Bengaluru Tuesday, September 17, 2024, 15:50 Hrs [IST] International Pharm ...
Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees: Our Bureau, Bengaluru Tuesday, September 17, 2024, 17:15 Hrs [IST] Novo Nord ...
Civil Society Organisations oppose Gilead's patent applications for lenacapavir in India: Our Bureau, New Delhi Tuesday, September 17, 2024, 15:40 Hrs [IST] Civil society organisa ...
Initial results from dose escalation in the first in-human phase 1 trial of DS-9606 suggest early promising clinical activity in patients with advanced solid tumours known to express Claudin-6 (CLDN6) ...
Tim Leest elected as new chair for EMA’s Orphan Medicinal Products Committee: Amsterdam, The Netherlands Tuesday, September 17, 2024, 12:00 Hrs [IST] The European Medicines Agen ...